Nelson Peltz's Trian Fund Management said in a letter to shareholders on Wednesday that medical device maker Solventum's separation from 3M has not been living up to its potential. In the letter, ...
M spinoff Solventum (NYSE:SOLV) briefly edged higher on a report that activist Trian had added to its previous position and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback